Nucs AI Announces Collaboration to Develop AI-driven Response Prediction for Next-Generation Therapeutic Radioconjugates

Collaboration with AstraZeneca is among the first pharma-industry investments exploring the use of a predictive image-based AI algorithm with therapeutic radioconjugates NEW YORK, May 29, 2026 /PRNewswire/ -- Nucs AI, an AI company developing diagnostic tools and predictive imaging...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.